Skip to main content

View full-text article in PMC

. 2003 Aug 26;89(5):831–833. doi: 10.1038/sj.bjc.6601220

Table 2. Human papillomavirus infections and the estimated risks for CIN.

	Case (n=141)	Control (n=109)	OR (95% CI)a
HPV DNA
Negative	36 (26%)	93 (85%)	1.0
Positive	105 (74%)	16 (15%)	17.9 (9.5–36.0)

HPV antibodiesb
Negative	65 (46%)	76 (70%)	1.0
Positive	76 (54%)	33 (30%)	2.7 (1.6–4.6)

^a

odds ratios and 95% confidence intervals adjusted for age.

^b

IgG antibodies to any type of HPV16/52/58 L1-capsids.